Historique
Périodique
Lofexidine and desipramine: interaction results in breakthrough opioid withdrawal symptoms
(Lofexidine (analogue à l'Estulic) et Pertrofan : interaction dans le syndrome de sevrage aux opiacés)
Auteur(s) :
KEANEY, F. ;
CRIMLISK H. ;
BEARN, J.
Année
2002
Page(s) :
179-181
Langue(s) :
Anglais
ISBN :
1365-1501
Refs biblio. :
8
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
SYNDROME DE SEVRAGE
;
OPIACES
;
DEPENDANCE
;
STIMULANTS
;
ANTIDEPRESSEURS
;
INTERACTION CHIMIQUE
Note générale :
International Journal of Psychiatry in Clinical Practice, 2002, 6, 179-181
Note de contenu :
fig.
Résumé :
ENGLISH :
A patient was receiving treatment for concurrent opioid and stimulant dependency. When desipramine was added to his lofexidine regimen for treatment of stimulant withdrawal, there was an exacerbation of opioid withdrawal symptoms. With the increasing use of lofexidine for opioid withdrawal, clinicians need to be aware of the potential for interactions with tricyclic antidepressants in the treatment of concomitant stimulant users. (Author's abstract.)
Affiliation :
Natl Addiction Ctr, Addiction Sci. Bldg, 4 Windsor Walk, London SE5 8 AF
Royaume-Uni. United Kingdom.
Royaume-Uni. United Kingdom.